What you'll learn

  • Explain the pathophysiology of HF and describe the diagnostic evaluation of a patient presenting with HF.

  • Describe current evidence-based medical and device therapeutics for HF. 

  • Identify HF with preserved and reduced ejection fraction phenotypes with use of CPET. 

  • Recognize the importance of co-managing HF patients with APPs and partner hospitals for advanced HF as well as need for lifestyle management, timely palliative care consultation, and ongoing need for equity. 

  • Understand the importance of early diagnosis of cardiogenic shock and timely institution of appropriate therapies.

  • Describe the indications and managements of temporary mechanical circulatory support.

     

Course description

This Comprehensive Mass General Brigham Heart Failure & Shock symposium will provide practical insights for all clinicians who manage patients with heart failure (HF) and cardiogenic shock. The first day of this three-day course will be an in-depth review of cardiogenic shock while the next two days focus on the latest HF innovations with an emphasis on the multidisciplinary approach to treating HF patients.

For the Shock course, expert speakers will address state-of-the-art issues including: up-to-date knowledge of cardiogenic shock pathophysiology, shock phenotypes, and trajectories; best practices in shock diagnosis and management; the roles of temporary mechanical circulatory support, and challenging case discussions.

For the HF course, leaders in the field will discuss: general HF management across the spectrum of EF, pathology of the failing heart, the fifth pillar - when medications are not enough, HFpEF GDMT in 2027, special cardiomyopathies, and genetic testing (valvular, hypertrophic, inflammatory, amyloid, and cancer-induced). There will be sessions on navigating special issues in the context of HF, such as pregnancy, obesity, and palliative care referral.

The symposium will illustrate the Mass General Brigham Heart Failure Section's comprehensive approach to the management of heart failure and cardiogenic shock for all cardiovascular clinicians.

You may also like

In-Person
Explore comprehensive, multidisciplinary strategies for managing heart failure—from outpatient care to advanced therapies—through expert-led sessions, case studies, and patient perspectives in this Harvard Medical School–accredited one-day summit.
Price
$175
Registration Deadline